CNEY (CNEY) Stock Price & Analysis
CNEY (CNEY) fell 4.68% to USD 0.86 as of June 10, 2026 at 00:28 UTC, according to Nexqual real-time market data.
CNEY last closed at USD 0.9; the session ranged USD 0.85–0.95 on volume of 170,606 shares. Market capitalization is $7.04M, with a 52-week range of USD 0.31–3.08 (NCM). Source: Nexqual, June 10, 2026 at 00:28 UTC.
Key Statistics (as of June 10, 2026 at 00:28 UTC)
| Price | USD 0.86 |
|---|---|
| Change | ▼ 4.68% (down) |
| Previous Close | USD 0.9 |
| Open | USD 0.9 |
| Day Range | USD 0.85 – 0.95 |
| 52-Week Range | USD 0.31 – 3.08 |
| Volume | 170,606 shares |
| Market Cap | $7.04M |
| Exchange | NCM |
Technical Analysis (CNEY)
Nexqual's technical model rates CNEY "NEUTRAL" based on 3 bullish and 3 bearish signals across 124 daily candles, as of June 10, 2026 at 00:28 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 42.31 (neutral) |
| vs SMA50 | Above (USD 0.83) |
| MACD | 0.02 (positive) |
Analyst Ratings (CNEY)
Wall Street analysts rate CNEY "None", per Nexqual as of June 10, 2026 at 00:28 UTC.
| Consensus Rating | None |
|---|
Earnings (CNEY)
Source: Nexqual, June 10, 2026 at 00:28 UTC.
Financials & Fundamentals (CNEY)
| Total Revenue | $35.57M |
|---|---|
| Revenue Growth (YoY) | -2.40% |
| Gross Margin | +1.82% |
| Operating Margin | -89.92% |
| Profit Margin | -31.32% |
| ROE | -11.20% |
| Debt / Equity | 3.37 |
| Current Ratio | 13.9 |
| Total Cash | $390,706 |
| Total Debt | $3.43M |
| Free Cash Flow | $-9.81M |
Source: Nexqual, June 10, 2026 at 00:28 UTC.
Financial Health Score (CNEY)
Nexqual rates CNEY's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 00:28 UTC.
| Growth | Weak — Revenue -2% YoY (latest Q), declining |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Strong — $391K cash vs $3M debt |
| Cash Flow | Weak — Operating cash flow -$2M |
| Efficiency | Critical — ROE -11%, ROA -6.7% |
Ownership (CNEY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +3.32% |
| Shares Outstanding | 7.57M |
| Float | 4.99M |
| Short % of Float | +3.12% |
Source: Nexqual, June 10, 2026 at 00:28 UTC.
Leadership (CNEY)
CNEY is led by Wenhua Liu (age 55), Interim CEO & Director, per Nexqual as of June 10, 2026 at 00:28 UTC.
| Interim CEO & Director | Wenhua Liu (age 55) |
|---|---|
| Chief Financial Officer | Jinwu Huang (age 50) |
Major Backers & Investors (CNEY)
Notable institutional backers of CNEY include Renaissance Technologies, Xtx Topco Ltd, Virtu Financial LLC, according to Nexqual as of June 10, 2026 at 00:28 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Renaissance Technologies | 0.98% |
| Xtx Topco Ltd | 0.37% |
| Virtu Financial LLC | 0.35% |
| Citadel | 0.32% |
| Two Sigma Securities, LLC | 0.17% |
Source: Nexqual, June 10, 2026 at 00:28 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| QH | Quhuo Limited - American Deposi | USD 3.42 | ▲ 0.88% |
| BAOS | Baosheng Media Group Holdings L | USD 2.88 | ▲ 12.5% |
| BON | Bon Natural Life Limited | USD 1.32 | ▲ 5.44% |
| BBLG | Bone Biologics Corp | USD 1.23 | ▼ 1.52% |
| TNON | Tenon Medical, Inc. | USD 0.62 | ▲ 2.12% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:28 UTC. This page is informational and not investment advice.